nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—ADRA1D—polycystic ovary syndrome	0.331	0.412	CbGaD
Methotrimeprazine—ADRA1B—polycystic ovary syndrome	0.282	0.351	CbGaD
Methotrimeprazine—ADRA1A—polycystic ovary syndrome	0.19	0.237	CbGaD
Methotrimeprazine—CYP1A2—urine—polycystic ovary syndrome	0.00131	0.0763	CbGeAlD
Methotrimeprazine—CYP2E1—urine—polycystic ovary syndrome	0.00118	0.0686	CbGeAlD
Methotrimeprazine—HTR2A—urine—polycystic ovary syndrome	0.00103	0.0596	CbGeAlD
Methotrimeprazine—CYP2D6—urine—polycystic ovary syndrome	0.000935	0.0543	CbGeAlD
Methotrimeprazine—DRD5—female gonad—polycystic ovary syndrome	0.000615	0.0357	CbGeAlD
Methotrimeprazine—DRD5—endocrine gland—polycystic ovary syndrome	0.000572	0.0332	CbGeAlD
Methotrimeprazine—Propericiazine—ADRA1B—polycystic ovary syndrome	0.00057	0.108	CrCbGaD
Methotrimeprazine—ADRA1D—endocrine gland—polycystic ovary syndrome	0.000458	0.0266	CbGeAlD
Methotrimeprazine—ADRA2C—adrenal cortex—polycystic ovary syndrome	0.000401	0.0233	CbGeAlD
Methotrimeprazine—CHRM3—adipose tissue—polycystic ovary syndrome	0.000369	0.0214	CbGeAlD
Methotrimeprazine—Acepromazine—ADRA1B—polycystic ovary syndrome	0.000366	0.0692	CrCbGaD
Methotrimeprazine—Thioproperazine—ADRA1B—polycystic ovary syndrome	0.000358	0.0677	CrCbGaD
Methotrimeprazine—ADRA2C—endometrium—polycystic ovary syndrome	0.000358	0.0208	CbGeAlD
Methotrimeprazine—CHRM2—endocrine gland—polycystic ovary syndrome	0.000352	0.0205	CbGeAlD
Methotrimeprazine—Propiomazine—ADRA1D—polycystic ovary syndrome	0.000343	0.0649	CrCbGaD
Methotrimeprazine—ADRA1A—adipose tissue—polycystic ovary syndrome	0.000338	0.0197	CbGeAlD
Methotrimeprazine—DRD2—pituitary gland—polycystic ovary syndrome	0.000333	0.0194	CbGeAlD
Methotrimeprazine—HTR2A—embryo—polycystic ovary syndrome	0.000332	0.0193	CbGeAlD
Methotrimeprazine—ADRA2C—uterus—polycystic ovary syndrome	0.00033	0.0192	CbGeAlD
Methotrimeprazine—ADRA2C—pituitary gland—polycystic ovary syndrome	0.000324	0.0188	CbGeAlD
Methotrimeprazine—ADRA2C—adipose tissue—polycystic ovary syndrome	0.000322	0.0187	CbGeAlD
Methotrimeprazine—CHRM1—endocrine gland—polycystic ovary syndrome	0.00032	0.0186	CbGeAlD
Methotrimeprazine—CHRM3—female gonad—polycystic ovary syndrome	0.000308	0.0179	CbGeAlD
Methotrimeprazine—ADRA1A—adrenal gland—polycystic ovary syndrome	0.000304	0.0176	CbGeAlD
Methotrimeprazine—Propiomazine—ADRA1B—polycystic ovary syndrome	0.000293	0.0554	CrCbGaD
Methotrimeprazine—HRH1—endometrium—polycystic ovary syndrome	0.000291	0.0169	CbGeAlD
Methotrimeprazine—ADRA2C—adrenal gland—polycystic ovary syndrome	0.000289	0.0168	CbGeAlD
Methotrimeprazine—CHRM3—endocrine gland—polycystic ovary syndrome	0.000287	0.0167	CbGeAlD
Methotrimeprazine—ADRA2A—endometrium—polycystic ovary syndrome	0.000286	0.0166	CbGeAlD
Methotrimeprazine—ADRA2C—female gonad—polycystic ovary syndrome	0.00027	0.0157	CbGeAlD
Methotrimeprazine—ADRA2C—vagina—polycystic ovary syndrome	0.000268	0.0156	CbGeAlD
Methotrimeprazine—ADRA1A—endocrine gland—polycystic ovary syndrome	0.000263	0.0153	CbGeAlD
Methotrimeprazine—ADRA2A—uterus—polycystic ovary syndrome	0.000263	0.0153	CbGeAlD
Methotrimeprazine—Thioridazine—ADRA1B—polycystic ovary syndrome	0.000262	0.0496	CrCbGaD
Methotrimeprazine—HRH1—adipose tissue—polycystic ovary syndrome	0.000262	0.0152	CbGeAlD
Methotrimeprazine—ADRA2A—pituitary gland—polycystic ovary syndrome	0.000258	0.015	CbGeAlD
Methotrimeprazine—DRD2—endocrine gland—polycystic ovary syndrome	0.000258	0.015	CbGeAlD
Methotrimeprazine—ADRA2A—adipose tissue—polycystic ovary syndrome	0.000257	0.015	CbGeAlD
Methotrimeprazine—Trimipramine—ADRA1B—polycystic ovary syndrome	0.000256	0.0484	CrCbGaD
Methotrimeprazine—Promazine—ADRA1D—polycystic ovary syndrome	0.000254	0.0481	CrCbGaD
Methotrimeprazine—Acepromazine—ADRA1A—polycystic ovary syndrome	0.000247	0.0466	CrCbGaD
Methotrimeprazine—Thioproperazine—ADRA1A—polycystic ovary syndrome	0.000241	0.0456	CrCbGaD
Methotrimeprazine—HRH1—adrenal gland—polycystic ovary syndrome	0.000235	0.0137	CbGeAlD
Methotrimeprazine—ADRA2A—adrenal gland—polycystic ovary syndrome	0.000231	0.0134	CbGeAlD
Methotrimeprazine—CYP2E1—adrenal gland—polycystic ovary syndrome	0.000226	0.0131	CbGeAlD
Methotrimeprazine—Imipramine—ADRA1D—polycystic ovary syndrome	0.000223	0.0421	CrCbGaD
Methotrimeprazine—HTR2A—pituitary gland—polycystic ovary syndrome	0.00022	0.0128	CbGeAlD
Methotrimeprazine—HRH1—female gonad—polycystic ovary syndrome	0.000219	0.0127	CbGeAlD
Methotrimeprazine—HRH1—vagina—polycystic ovary syndrome	0.000218	0.0127	CbGeAlD
Methotrimeprazine—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000218	0.0127	CbGeAlD
Methotrimeprazine—Promazine—ADRA1B—polycystic ovary syndrome	0.000217	0.041	CrCbGaD
Methotrimeprazine—ADRA2A—female gonad—polycystic ovary syndrome	0.000215	0.0125	CbGeAlD
Methotrimeprazine—ADRA2A—vagina—polycystic ovary syndrome	0.000214	0.0124	CbGeAlD
Methotrimeprazine—HRH1—endocrine gland—polycystic ovary syndrome	0.000204	0.0118	CbGeAlD
Methotrimeprazine—ADRA2A—endocrine gland—polycystic ovary syndrome	0.0002	0.0116	CbGeAlD
Methotrimeprazine—Propiomazine—ADRA1A—polycystic ovary syndrome	0.000197	0.0373	CrCbGaD
Methotrimeprazine—HTR2A—adrenal gland—polycystic ovary syndrome	0.000196	0.0114	CbGeAlD
Methotrimeprazine—CYP2E1—endocrine gland—polycystic ovary syndrome	0.000196	0.0114	CbGeAlD
Methotrimeprazine—Chlorpromazine—ADRA1B—polycystic ovary syndrome	0.000191	0.0361	CrCbGaD
Methotrimeprazine—Imipramine—ADRA1B—polycystic ovary syndrome	0.00019	0.0359	CrCbGaD
Methotrimeprazine—HTR2A—vagina—polycystic ovary syndrome	0.000182	0.0106	CbGeAlD
Methotrimeprazine—Thioridazine—ADRA1A—polycystic ovary syndrome	0.000177	0.0334	CrCbGaD
Methotrimeprazine—Trimipramine—ADRA1A—polycystic ovary syndrome	0.000172	0.0326	CrCbGaD
Methotrimeprazine—HTR2A—endocrine gland—polycystic ovary syndrome	0.00017	0.00989	CbGeAlD
Methotrimeprazine—CYP2D6—female gonad—polycystic ovary syndrome	0.000167	0.00969	CbGeAlD
Methotrimeprazine—Promethazine—ADRA1A—polycystic ovary syndrome	0.000166	0.0314	CrCbGaD
Methotrimeprazine—Trifluoperazine—ADRA1A—polycystic ovary syndrome	0.000164	0.031	CrCbGaD
Methotrimeprazine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000155	0.00901	CbGeAlD
Methotrimeprazine—Promazine—ADRA1A—polycystic ovary syndrome	0.000146	0.0276	CrCbGaD
Methotrimeprazine—Chlorpromazine—ADRA1A—polycystic ovary syndrome	0.000129	0.0243	CrCbGaD
Methotrimeprazine—Imipramine—ADRA1A—polycystic ovary syndrome	0.000128	0.0242	CrCbGaD
Methotrimeprazine—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	4.41e-06	2.53e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—POMC—polycystic ovary syndrome	4.41e-06	2.53e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—GNAS—polycystic ovary syndrome	4.4e-06	2.52e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IRS1—polycystic ovary syndrome	4.38e-06	2.51e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—INS—polycystic ovary syndrome	4.38e-06	2.51e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—CYP1A1—polycystic ovary syndrome	4.36e-06	2.5e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	4.36e-06	2.5e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.35e-06	2.5e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	4.35e-06	2.49e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—IGF1—polycystic ovary syndrome	4.3e-06	2.46e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.3e-06	2.46e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—AKT2—polycystic ovary syndrome	4.3e-06	2.46e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	4.28e-06	2.45e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IRS2—polycystic ovary syndrome	4.26e-06	2.44e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—IGF1—polycystic ovary syndrome	4.24e-06	2.43e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—AKT2—polycystic ovary syndrome	4.24e-06	2.43e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.23e-06	2.42e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	4.22e-06	2.42e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—POMC—polycystic ovary syndrome	4.22e-06	2.42e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.22e-06	2.42e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	4.22e-06	2.42e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.21e-06	2.41e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—INS—polycystic ovary syndrome	4.2e-06	2.41e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.19e-06	2.4e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	4.18e-06	2.4e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—LEP—polycystic ovary syndrome	4.17e-06	2.39e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.15e-06	2.38e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—NRG1—polycystic ovary syndrome	4.15e-06	2.38e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—NRG1—polycystic ovary syndrome	4.14e-06	2.37e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.14e-06	2.37e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	4.13e-06	2.37e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IRS1—polycystic ovary syndrome	4.12e-06	2.36e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IRS1—polycystic ovary syndrome	4.12e-06	2.36e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NRG1—polycystic ovary syndrome	4.11e-06	2.36e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	4.11e-06	2.36e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IRS2—polycystic ovary syndrome	4.09e-06	2.35e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.09e-06	2.34e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.08e-06	2.34e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	4.07e-06	2.34e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—MTHFR—polycystic ovary syndrome	4.07e-06	2.33e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	4.06e-06	2.33e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IGF1—polycystic ovary syndrome	4.06e-06	2.33e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	4.06e-06	2.33e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—PPARG—polycystic ovary syndrome	4.06e-06	2.33e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—AKT2—polycystic ovary syndrome	4.06e-06	2.33e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	4.04e-06	2.32e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.03e-06	2.31e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.03e-06	2.31e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—POMC—polycystic ovary syndrome	4.02e-06	2.31e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—LEP—polycystic ovary syndrome	4.01e-06	2.3e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	4e-06	2.3e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—POMC—polycystic ovary syndrome	4e-06	2.3e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—INS—polycystic ovary syndrome	4e-06	2.29e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IRS2—polycystic ovary syndrome	3.98e-06	2.28e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—INS—polycystic ovary syndrome	3.98e-06	2.28e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—POMC—polycystic ovary syndrome	3.97e-06	2.28e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—POMC—polycystic ovary syndrome	3.97e-06	2.28e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—INS—polycystic ovary syndrome	3.95e-06	2.26e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—INS—polycystic ovary syndrome	3.95e-06	2.26e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IRS2—polycystic ovary syndrome	3.92e-06	2.25e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—LEP—polycystic ovary syndrome	3.9e-06	2.23e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	3.87e-06	2.22e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	3.87e-06	2.22e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.86e-06	2.21e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	3.85e-06	2.21e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.85e-06	2.21e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—LEP—polycystic ovary syndrome	3.83e-06	2.2e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	3.83e-06	2.2e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IGF1—polycystic ovary syndrome	3.82e-06	2.19e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IGF1—polycystic ovary syndrome	3.82e-06	2.19e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—AKT2—polycystic ovary syndrome	3.82e-06	2.19e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—AKT2—polycystic ovary syndrome	3.82e-06	2.19e-05	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.8e-06	2.18e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	3.78e-06	2.17e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	3.77e-06	2.16e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	3.75e-06	2.15e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	3.73e-06	2.14e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IRS1—polycystic ovary syndrome	3.72e-06	2.13e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.67e-06	2.11e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.63e-06	2.08e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.63e-06	2.08e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	3.61e-06	2.07e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	3.59e-06	2.06e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—POMC—polycystic ovary syndrome	3.58e-06	2.05e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IRS1—polycystic ovary syndrome	3.57e-06	2.05e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—INS—polycystic ovary syndrome	3.56e-06	2.04e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	3.55e-06	2.04e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	3.55e-06	2.03e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—POMC—polycystic ovary syndrome	3.54e-06	2.03e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	3.54e-06	2.03e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	3.54e-06	2.03e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	3.53e-06	2.02e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	3.52e-06	2.02e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—INS—polycystic ovary syndrome	3.52e-06	2.02e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	3.49e-06	2e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	3.48e-06	2e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	3.48e-06	1.99e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IRS1—polycystic ovary syndrome	3.48e-06	1.99e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	3.47e-06	1.99e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	3.46e-06	1.98e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	3.45e-06	1.98e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IGF1—polycystic ovary syndrome	3.45e-06	1.98e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—AKT2—polycystic ovary syndrome	3.44e-06	1.98e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—POMC—polycystic ovary syndrome	3.44e-06	1.97e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—INS—polycystic ovary syndrome	3.42e-06	1.96e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	3.42e-06	1.96e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	3.42e-06	1.96e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	3.41e-06	1.95e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—POMC—polycystic ovary syndrome	3.35e-06	1.92e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—INS—polycystic ovary syndrome	3.33e-06	1.91e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IGF1—polycystic ovary syndrome	3.31e-06	1.9e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—AKT2—polycystic ovary syndrome	3.31e-06	1.9e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	3.3e-06	1.89e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	3.29e-06	1.89e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—IL6—polycystic ovary syndrome	3.29e-06	1.88e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	3.28e-06	1.88e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.27e-06	1.88e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—TH—polycystic ovary syndrome	3.27e-06	1.87e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	3.25e-06	1.86e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—IL6—polycystic ovary syndrome	3.24e-06	1.86e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	3.23e-06	1.85e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—INS—polycystic ovary syndrome	3.23e-06	1.85e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IGF1—polycystic ovary syndrome	3.22e-06	1.85e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—AKT2—polycystic ovary syndrome	3.22e-06	1.85e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	3.18e-06	1.82e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	3.17e-06	1.82e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	3.17e-06	1.82e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	3.16e-06	1.81e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	3.15e-06	1.81e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	3.15e-06	1.8e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.14e-06	1.8e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—IL6—polycystic ovary syndrome	3.11e-06	1.78e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	3.1e-06	1.78e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	3.1e-06	1.78e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	3.09e-06	1.77e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	3.08e-06	1.76e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.06e-06	1.75e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	3.05e-06	1.75e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	3.04e-06	1.74e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	3.04e-06	1.74e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	3.03e-06	1.74e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	3.02e-06	1.73e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.01e-06	1.73e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	3e-06	1.72e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	2.99e-06	1.71e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	2.99e-06	1.71e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	2.99e-06	1.71e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	2.98e-06	1.71e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	2.97e-06	1.7e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	2.97e-06	1.7e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—INS—polycystic ovary syndrome	2.97e-06	1.7e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	2.97e-06	1.7e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	2.96e-06	1.7e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	2.96e-06	1.7e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	2.96e-06	1.7e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	2.95e-06	1.69e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	2.93e-06	1.68e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	2.93e-06	1.68e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	2.92e-06	1.68e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—IL6—polycystic ovary syndrome	2.92e-06	1.67e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—IL6—polycystic ovary syndrome	2.92e-06	1.67e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	2.92e-06	1.67e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	2.92e-06	1.67e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	2.91e-06	1.67e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.87e-06	1.65e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.87e-06	1.65e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	2.87e-06	1.64e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	2.87e-06	1.64e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	2.86e-06	1.64e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	2.86e-06	1.64e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	2.85e-06	1.63e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	2.85e-06	1.63e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	2.84e-06	1.63e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	2.82e-06	1.62e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	2.82e-06	1.62e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	2.82e-06	1.62e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.81e-06	1.61e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.81e-06	1.61e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.81e-06	1.61e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.77e-06	1.59e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.77e-06	1.59e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.73e-06	1.57e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.72e-06	1.56e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	2.72e-06	1.56e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.72e-06	1.56e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.71e-06	1.55e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	2.7e-06	1.55e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.68e-06	1.54e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.67e-06	1.53e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	2.67e-06	1.53e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.65e-06	1.52e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	2.65e-06	1.52e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—IL6—polycystic ovary syndrome	2.64e-06	1.51e-05	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—IL6—polycystic ovary syndrome	2.63e-06	1.51e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.62e-06	1.5e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.61e-06	1.5e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	2.54e-06	1.46e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—IL6—polycystic ovary syndrome	2.53e-06	1.45e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.53e-06	1.45e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.49e-06	1.43e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.49e-06	1.43e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.48e-06	1.42e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—IL6—polycystic ovary syndrome	2.46e-06	1.41e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	2.42e-06	1.39e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	2.41e-06	1.38e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.25e-06	1.29e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	2.24e-06	1.29e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	2.23e-06	1.28e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.2e-06	1.26e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	2.19e-06	1.26e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	2.19e-06	1.25e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	2.18e-06	1.25e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.16e-06	1.24e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	2.16e-06	1.24e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.15e-06	1.23e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	2.15e-06	1.23e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	2.12e-06	1.22e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	2.11e-06	1.21e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.1e-06	1.21e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.07e-06	1.19e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	2e-06	1.15e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—IL6—polycystic ovary syndrome	1.94e-06	1.11e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—IL6—polycystic ovary syndrome	1.92e-06	1.1e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.91e-06	1.09e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.88e-06	1.08e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.87e-06	1.07e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.87e-06	1.07e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.86e-06	1.07e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.84e-06	1.06e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.84e-06	1.05e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IL6—polycystic ovary syndrome	1.83e-06	1.05e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	1.82e-06	1.04e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	1.79e-06	1.03e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—INS—polycystic ovary syndrome	1.78e-06	1.02e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IL6—polycystic ovary syndrome	1.75e-06	1e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IL6—polycystic ovary syndrome	1.72e-06	9.89e-06	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IL6—polycystic ovary syndrome	1.72e-06	9.89e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.71e-06	9.8e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IL6—polycystic ovary syndrome	1.56e-06	8.93e-06	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IL6—polycystic ovary syndrome	1.5e-06	8.58e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IL6—polycystic ovary syndrome	1.45e-06	8.34e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	1.43e-06	8.21e-06	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	1.32e-06	7.57e-06	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	1.3e-06	7.45e-06	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	1.3e-06	7.43e-06	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	1.29e-06	7.41e-06	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	1.29e-06	7.38e-06	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	1.28e-06	7.31e-06	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	1.27e-06	7.29e-06	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	1.18e-06	6.78e-06	CbGpPWpGaD
